<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Great importance has been attributed to <z:chebi fb="11" ids="22586">antioxidants</z:chebi> in the treatment of conditions associated with <z:mp ids='MP_0003674'>oxidative stress</z:mp> for many years </plain></SENT>
<SENT sid="1" pm="."><plain>At the same time the <z:chebi fb="11" ids="22586">antioxidants</z:chebi> can exert prooxidant activity </plain></SENT>
<SENT sid="2" pm="."><plain>Combined <z:chebi fb="11" ids="22586">antioxidant</z:chebi> treatment is more favourable compared with monotherapy, because <z:chebi fb="11" ids="22586">antioxidants</z:chebi> have scavenger-, compartment- and tissue-specificity and they regenerate each other directly, too </plain></SENT>
<SENT sid="3" pm="."><plain>Drugs of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver diseases</z:e> should be considered because of the role of liver in biotransformation </plain></SENT>
<SENT sid="4" pm="."><plain>Our aim was to study the redox status of liver and investigate the effects of natural <z:chebi fb="11" ids="22586">antioxidants</z:chebi> (vegetable lyophilizates, silymarin, metadoxine) on liver redox status </plain></SENT>
<SENT sid="5" pm="."><plain>Besides of clinical diagnosis, biochemical, analytical, histological methods were used to assess the free radical-<z:chebi fb="11" ids="22586">antioxidant</z:chebi> balance on the whole </plain></SENT>
<SENT sid="6" pm="."><plain>Our in vitro methodological system is suitable for screening natural compounds for primary and secondary <z:chebi fb="11" ids="22586">antioxidant</z:chebi> property as well as membrane-stabilizing activity </plain></SENT>
<SENT sid="7" pm="."><plain>A shift in free radical-<z:chebi fb="11" ids="22586">antioxidant</z:chebi> balance was proved in short-term extrahepatic <z:hpo ids='HP_0001396'>cholestasis</z:hpo>, <z:chebi fb="11" ids="22586">antioxidant</z:chebi>-type choleretic compounds can be investigated in this animal model </plain></SENT>
<SENT sid="8" pm="."><plain>In human experiments redox status was investigated in the <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's disease</z:e> and in the most frequent <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disorder</z:e> in Hungary, in <z:e sem="disease" ids="C0023896" disease_type="Disease or Syndrome" abbrv="">alcoholic liver disease</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The improvement of non-enzymatic <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defence system was found in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's disease</z:e> without the alteration of free radical-<z:chebi fb="11" ids="22586">antioxidant</z:chebi> balance </plain></SENT>
<SENT sid="10" pm="."><plain>Our results proved the role of free radical reactions in <z:e sem="disease" ids="C0023896" disease_type="Disease or Syndrome" abbrv="">alcoholic liver disease</z:e> and underlined the greater women vulnerability to alcohol toxicity </plain></SENT>
<SENT sid="11" pm="."><plain>The chemiluminometric measurements in erythrocytes is suitable for the estimation of progression of <z:e sem="disease" ids="C0023896" disease_type="Disease or Syndrome" abbrv="">alcoholic liver disease</z:e> and of efficacy of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> therapy </plain></SENT>
</text></document>